Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | TAOK3 | Q9H2K8 | 6/20 | 0.55 |
| ▸ | TAOK1 | Q7L7X3 | 6/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
| ▸ | NAMPT | P43490 | 6/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31458292 | 1.00 | ALDH1A1 (0.57) | ALDH1A1L3MBTL1TAOK3TAOK1HTT | |
| SCHEMBL5653764 | 0.92 | ALDH1A1 (0.69) | ALDH1A1L3MBTL1TAOK3TAOK1HTT | |
| SCHEMBL31458352 | 0.92 | ALDH1A1 (0.69) | ALDH1A1L3MBTL1TAOK3TAOK1HTT | |
| SCHEMBL5652343 | 0.81 | MAPT (0.58) | TAOK3TAOK1RAB9AP2RY12 | |
| SCHEMBL14422178 | 0.78 | TAOK1 (0.56) | TAOK3TAOK1OPRM1OPRK1OPRD1 | |
| SCHEMBL13983486 | 0.75 | KMT2A (0.62) | ALDH1A1L3MBTL1SMN1; SMN2RAB9AP2RY12 | |
| SCHEMBL14422176 | 0.73 | TAOK1 (0.73) | ALDH1A1TAOK3TAOK1NPC1RAB9A | |
| SCHEMBL13058919 | 0.72 | RAB9A (0.59) | ALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL32676758 | 0.72 | OPRM1 (0.58) | TAOK3TAOK1OPRM1OPRK1OPRD1 | |
| SCHEMBL32676662 | 0.72 | OPRM1 (0.58) | TAOK3TAOK1OPRM1OPRK1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070208166-A1 | Tao Kinase Modulators And Method Of Use | EXELIXIS, INC. (US) | 2007-09-06 | — | — | US | claimed |
| US-20070208166-A1 | Tao Kinase Modulators And Method Of Use | EXELIXIS, INC. (US) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208166-A1 | Tao Kinase Modulators And Method Of Use | TAOK1, TAOK3, MAP3K6 | ALDH1A1 4424/4885L3MBTL1 1991/4885TAOK3 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.